News & Events

Astellas Establishes Open Innovation Hub for Tumor Microenvironment Research with Cutting-Edge Spatial Biology, in Mitsui Fudosan’s “MITSUI LINK-Lab KASHIWA-NO-HA 1”

TOKYO, June 29, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Mitsui Fudosan Co., Ltd. (TSE: 8801, President and CEO: Takashi Ueda, “Mitsui Fudosan”) announced today that Astellas will establish a “TME imaging and interactive research for innovation (TME iLab)” open innovation hub in October, 2023 in “MITSUI LINK-Lab KASHIWA-NO-HA 1” (Kashiwa City, Chiba Prefecture, “the Lab”) operated by Mitsui Fudosan.

Read the full press release from Astellas.